GlassScriptPhysician profile
Galen Perdikis
NPI 1699765511
$7,434.65
in general payments reported to CMS, 2019-2025
12 companies · $2,521 in 2025
The $2,521 reported for 2025 was more than what 86% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $268 · 2021: $256 · 2022: $442 · 2023: $551 · 2024: $2,271 · 2025: $2,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,035 · Education: $1,500 · Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,034.71 |
| Education | $1,500.00 |
| Food and Beverage | $808.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,480.16 | 2024-2025 | |
| Acera Surgical, INC. | $1,324.49 | 2022-2024 | Restrata Wound Matrix |
| Axogen | $1,270.89 | 2019-2020 | |
| Allergan, INC. | $344.15 | 2022 | |
| Motiva USA, LLC | $220.66 | 2025 | |
| Mentor Worldwide LLC | $209.56 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Bard Peripheral Vascular, INC. | $146.68 | 2021 | |
| Innovation Technologies INC | $142.62 | 2021-2023 | Irrisept |
| Zimmer Biomet Holdings, INC. | $123.13 | 2019 | |
| Integra Lifesciences Corporation | $100.39 | 2023 | Durasorb Monofilament Mesh |
| Abbvie INC. | $38.03 | 2025 | |
| Tela Bio, INC. | $33.89 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Galen Perdikis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.